Details of the Drug Formulaction

General Information of Drug Formulation (ID: F16087)

• Formulation Name: Oxaprozin 600 mg tablet
• Company: AvKARE; Caraco Pharmaceutical Laboratories; DirectRX

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Oxaprozin	(DM9UB0P)	Osteoarthritis	FA00-FA05	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Polysorbate 80	(E00665)	Not Available	Dispersing agent; Emollient; Emulsifying agent; Plasticizing agent; Solubilizing agent; Surfactant; Suspending agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent